Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety and Efficacy of Ipamorelin Compared to Placebo for the Management of Post-Operative Ileus in Patients

NCT00672074 is registered in ClinicalTrials.gov with Helsinn Therapeutics (U.S.), Inc as lead sponsor.

NCT NCT00672074
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00672074 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety and Efficacy of Ipamorelin Compared to Placebo for the Management of Post-Operative Ileus in Patients
Lead sponsor
Helsinn Therapeutics (U.S.), Inc
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2008
Completion date
December 31, 2009
Enrollment
117 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

ileus